International Stem Cell Corporation and Absorption Systems Announce Potential Stem Cell Alternative to Live Animal Testing for Corneal Damage
OCEANSIDE, Calif. & EXTON, Pa.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB:ISCO)), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces… Read more »
International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
First Company To Grow Human Corneal Tissue From Stem Cells Oceanside, California, January 13, 2009 — International Stem Cell Corporation (OTCBB: ISCO) has created layered human tissue… Read more »